Efficacy of ketamine in the treatment of depressive disorder

Phase 4

Recruiting

• Conditions: Bipolar depression.; Bipolar disorder

• Registration Number: IRCT20101130005280N58
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients who have received a depressive episode by a doctor diagnosing bipolar disorder (one and two)
In the last two weeks (since the start of sampling) there has been no significant change in their medication regimen

Exclusion Criteria

Patients with severe physical illness (especially hypertension)
History of substance use and dependence in the past month

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Depression. Timepoint: base line and 90 minutes, 1 day, 7 days, 30 days and 60 days after infusion. Method of measurement: Hamilton depression questionnaire.;Anxiety. Timepoint: base line and 90 minutes, 1 day, 7 days, 30 days and 60 days after infusion. Method of measurement: Beck anxiety scale.